Adagio Medical Holdings (ADGM) Cash from Financing Activities (2023 - 2024)

Adagio Medical Holdings (ADGM) reported Cash from Financing Activities of $5.1 million for Q2 2024, down 47.01% quarter-over-quarter from $9.6 million in Q1 2024.

Adagio Medical Holdings (ADGM) Cash from Financing Activities (2023 - 2024) Analysis & Trends

Adagio Medical Holdings (ADGM) has 2 years of Cash from Financing Activities data on file, last reported at $5.1 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Adagio Medical Holdings 15.88 Mn 2.97 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 5.07 Mn
Jun 30, 2024 5.07 Mn
Mar 31, 2024 9.57 Mn
Mar 31, 2024 9.57 Mn
Dec 31, 2023 6.58 Mn
Dec 31, 2023 6.58 Mn